$0.1456
-0.0043[-2.87%]
At close: Jun 7
$0.1456
0[0.00%]
After Hours: 7:56PM EDT
Biolase
(NASDAQ:BIOL)Biolase Stock (NASDAQ:BIOL), Quotes and News Summary
Biolase Stock (NASDAQ: BIOL) stock price, news, charts, stock research, profile.
| Open | $0.149 |
| Close | $0.145 |
| Volume / Avg. | 1.036M / 4.815M |
| Day Range | 0.141 - 0.151 |
| 52 Wk Range | 0.125 - 10.310 |
| Market Cap | $4.862M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 42 |
| Short Interest | 5% |
| Days to Cover | 1 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Biolase (BIOL) stock?
You can purchase shares of Biolase (NASDAQ: BIOL) through any online brokerage.
Who are Biolase's (BIOL) competitors?
Other companies in Biolase’s space includes: Catheter Precision (AMEX:VTAK), Predictive Oncology (NASDAQ:POAI), Nexalin Technology (NASDAQ:NXL), Venus Concept (NASDAQ:VERO) and Talis Biomedical (NASDAQ:TLIS).
What is the target price for Biolase (BIOL) stock?
The latest price target for Biolase (NASDAQ: BIOL) was reported by Benchmark on Tuesday, May 14, 2024. The analyst firm set a price target for 0.40 expecting BIOL to rise to within 12 months (a possible 174.73% upside). 3 analyst firms have reported ratings in the last year.
Current Stock Price for Biolase (BIOL)?
The stock price for Biolase (NASDAQ: BIOL) is $0.1456 last updated June 7, 2024 at 7:56 PM EDT.
Does Biolase (BIOL) pay a dividend?
A quarterly cash dividend of $0.01 per share of Class A Common Stock. The quarterly cash dividend was payable on June 28, 2013 to stockholders of record on June 12, 2013.
When is Biolase (NASDAQ:BIOL) reporting earnings?
Biolase’s Q2 earnings are confirmed for Thursday, August 8, 2024.
Is Biolase (BIOL) going to split?
There is no upcoming split for Biolase.
What sector and industry does Biolase (BIOL) operate in?
Biolase is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.